BeOne Medicines Ltd
56 hedge funds and large institutions have $645M invested in BeOne Medicines Ltd in 2017 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 9 closing their positions.
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
28% more capital invested
Capital invested by funds: $504M → $645M (+$140M)
4% more funds holding
Funds holding: 54 → 56 (+2)
0.1% more ownership
Funds ownership: 3.3% → 3.4% (+0.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAM
Myriad Asset Management
North Point,
Hong Kong
|
+$12M |
| 2 |
BlackRock
New York
|
+$9.49M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.26M |
| 4 |
ACM
Ariose Capital Management
Central, Hong Kong,
Hong Kong
|
+$5.83M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$4.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FI
Fosun International
Hong Kong,
China
|
-$3.81M |
| 2 |
Millennium Management
New York
|
-$3.14M |
| 3 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$1.87M |
| 4 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$1.52M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$1.41M |
ONC Hedge Fund Activity: Q1 2017 in Review
56 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2017, worth a combined $645M — up 28% from $504M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new ONC positions and 9 closed out — a net gain of 4 holders — while 20 added to existing stakes and 11 trimmed.
The largest buyer was Myriad Asset Management, opening a new position worth an estimated $12M. The largest seller was Fosun International, cutting an estimated $3.81M.
- 56 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2017, up from 54 in Q4 2016.
- Funds reported $645M of BeOne Medicines Ltd stock for Q1 2017, up 28% quarter-over-quarter.
- 13 funds opened new BeOne Medicines Ltd positions in Q1 2017 and 9 closed out, a net change of +4 holders.
- The largest BeOne Medicines Ltd buyer in Q1 2017 was Myriad Asset Management, an estimated $12M added.
- The largest BeOne Medicines Ltd seller in Q1 2017 was Fosun International, an estimated $3.81M sold.
Based on aggregated 13F filings for Q1 2017.